{"drugs":["Ammonium Chloride"],"mono":{"0":{"id":"26180-s-0","title":"Generic Names","mono":"Ammonium Chloride"},"1":{"id":"26180-s-1","title":"Dosing and Indications","sub":{"0":{"id":"26180-s-1-4","title":"Adult Dosing","mono":"<b>Hypochloremia:<\/b> specific dosage dependent on the condition and tolerance of the patient; administer IV at a rate not to exceed 5 mL\/min "},"3":{"id":"26180-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Hypochloremia<\/li><li>Metabolic alkalosis<\/li><\/ul>"}}},"3":{"id":"26180-s-3","title":"Contraindications\/Warnings","sub":[{"id":"26180-s-3-9","title":"Contraindications","mono":"<ul><li>Severe renal impairment<\/li><li>Severely reduced liver function<\/li><li>Metabolic alkalosis due to vomiting of hydrochloric acid accompanied by sodium loss (excretion of sodium bicarbonate in the urine)<\/li><\/ul>"},{"id":"26180-s-3-10","title":"Precautions","mono":"<ul><li>Ammonia toxicity may occur; observe constantly for signs and symptoms of toxicity (pallor, sweating, retching, irregular breathing, bradycardia, cardiac arrhythmias, local and general twitching, tonic convulsions and coma)<\/li><li>Primary respiratory acidosis with high total carbon dioxide and buffer base<\/li><li>Rapid IV administration; local irritation and toxic effects may occur; IV administration should be slow<\/li><\/ul>"},{"id":"26180-s-3-11","title":"Pregnancy Category","mono":"A (AUS)<br\/>"},{"id":"26180-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"26180-s-5","title":"Adverse Effects","mono":"<b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Cardiac dysrhythmia<\/li><li><b>Neurologic:<\/b>Coma<\/li><li><b>Other:<\/b>Injection site infection<\/li><\/ul>"},"6":{"id":"26180-s-6","title":"Drug Name Info","sub":{"2":{"id":"26180-s-6-19","title":"Class","mono":"Urinary Acidifier<br\/>"},"3":{"id":"26180-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"26180-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"26180-s-9","title":"Administration","mono":"<b>Intravenous<\/b><br\/><ul><li>must dilute prior to administration; dilute 1 to 2 vials (100 mEq to 200 mEq) in 500 mL to 1000 mL of NS; diluted concentration should not exceed 1% to 2%<\/li><li>rate of infusion should not exceed 5 mL\/min<\/li><\/ul>"},"11":{"id":"26180-s-11","title":"How Supplied","mono":"<b>Generic<\/b><br\/>Intravenous Solution: 5 MEQ\/ML<br\/>"}}}